Treatment patterns in paediatric patients with a new diagnosis of gastroesophageal reflux disease

European Journal of Gastroenterology and Hepatology

Volumn 23, Issue 3, 2011, Pages 232-237

  Ruigómez, Ana ^a   Hungin, A Pali ^b   Lundborg, Per ^c   Johansson, Saga ^c   Wallander, Mari Ann ^d   García Rodríguez, Luis A ^a  

^a Spanish Centre for Pharmacoepidemiologic Research ^*  (Spain)

^b DURHAM UNIVERSITY   (United Kingdom)

^c ASTRAZENECA R AND D   (Sweden)

^d UPPSALA UNIVERSITY   (Sweden)

Author keywords

gastroesophageal reflux disease; paediatrics; prescription treatment; primary care

Indexed keywords

ANTACID AGENT; HISTAMINE H2 RECEPTOR ANTAGONIST; PROKINETIC AGENT; PROTON PUMP INHIBITOR;

ADOLESCENT; ARTICLE; CHILD; FEMALE; FOLLOW UP; GASTROESOPHAGEAL REFLUX; HUMAN; MAJOR CLINICAL STUDY; MALE; PRESCHOOL CHILD; PRESCRIPTION; PRIORITY JOURNAL; SCHOOL CHILD; TREATMENT DURATION;

ADOLESCENT; ANTACIDS; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; FEMALE; GASTROESOPHAGEAL REFLUX; GASTROINTESTINAL AGENTS; HISTAMINE H2 ANTAGONISTS; HUMANS; INFANT; MALE; PRIMARY HEALTH CARE; PROTON PUMP INHIBITORS; RETROSPECTIVE STUDIES; SEX FACTORS; TREATMENT OUTCOME;

EID: 79951947620     PISSN: 0954691X     EISSN: None     Source Type: Journal    
DOI: 10.1097/MEG.0b013e328343b06e     Document Type: Article

References (27)

1. Dent J, El-Serag HB, Wallander MA, Johansson S. Epidemiology of gastrooesophageal reflux disease: a systematic review. Gut 2005; 54:710-717. (Pubitemid 40559260)
2. Ruigomez A, Wallander MA, Lundborg P, Johansson S, Rodriguez LA. Gastroesophageal reflux disease in children and adolescents in primary care. Scand J Gastroenterol 2010; 45:139-146.
3. Ashorn M, Ruuska T, Karikoski R, Laippala P. The natural course of gastroesophageal reflux disease in children. Scand J Gastroenterol 2002; 37:638-641. (Pubitemid 34620923)
4. El-Serag HB, Gilger M, Carter J, Genta RM, Rabeneck L. Childhood GERD is a risk factor for GERD in adolescents and young adults. Am J Gastroenterol 2004; 99:806-812. (Pubitemid 39090204)
5. El-Serag HB, Richardson P, Pilgrim P, Gilger MA. Determinants of gastroesophageal reflux disease in adults with a history of childhood gastroesophageal reflux disease. Clin Gastroenterol Hepatol 2007; 5:696-701. (Pubitemid 46830058)
6. Martin AJ, Pratt N, Kennedy JD, Ryan P, Ruffin RE, Miles H, Marley J. Natural history and familial relationships of infant spilling to 9 years of age. Pediatrics 2002; 109:1061-1067. (Pubitemid 34587431)
7. Nelson SP, Chen EH, Syniar GM, Christoffel KK. One-year follow-up of symptoms of gastroesophageal reflux during infancy. Pediatric Practice Research Group. Pediatrics 1998; 102:E67.
8. Treem WR, Davis PM, Hyams JS. Gastroesophageal reflux in the older child: presentation, response to treatment and long-term follow-up. Clin Pediatr (Phila) 1991; 30:435-440.
9. Waring JP, Feiler MJ, Hunter JG, Smith CD, Gold BD. Childhood gastroesophageal reflux symptoms in adult patients. J Pediatr Gastroenterol Nutr 2002; 35:334-338.
10. Young RJ, Lyden E, Ward B, Vanderhoof JA, DiBaise JK. A retrospective, case-control pilot study of the natural history of pediatric gastroesophageal reflux. Dig Dis Sci 2007; 52:457-462. (Pubitemid 46202821)
11. Sturkenboom MC, Verhamme KM, Nicolosi A, Murray ML, Neubert A, Caudri D, et al. Drug use in children: cohort study in three European countries. PG-a2245 LID-337/nov24-2/a2245 [pii] LID-10.1136/bmj.a2245 [doi]. BMJ 2008; 337:a2245.
12. Hassall E, Kerr W, El-Serag HB. Characteristics of children receiving proton pump inhibitors continuously for up to 11 years duration. J Pediatrics 2007; 150:262-267.
13. Gold BD, Gunasekaran T, Tolia V, Wetzler G, Conter H, Traxler B, Illueca M. Safety and symptom improvement with esomeprazole in adolescents with gastroesophageal reflux disease. J Pediatr Gastroenterol Nutr 2007; 45:520-529. (Pubitemid 350307136)
14. Gold BD, Freston JW. Gastroesophageal reflux in children: pathogenesis, prevalence, diagnosis, and role of proton pump inhibitors in treatment. Paediatric Drugs 2002; 4:673-685. (Pubitemid 35168451)
15. Hassall E, Israel D, Shepherd R, Radke M, Dalvag A, Skold B, et al.; International Pediatric Omeprazole Study Group. Omeprazole for treatment of chronic erosive esophagitis in children: a multicenter study of efficacy, safety, tolerability and dose requirements. J Pediatr 2000; 137:800-807.
16. Tolia V, Ferry G, Gunasekaran T, Huang B, Keith R, Book L. Efficacy of lansoprazole in the treatment of gastroesophageal reflux disease in children. J Pediatr Gastroenterol Nutr 2002; 35 (Suppl 4):S308-S318. (Pubitemid 35416901)
17. Cucchiara S, Gobio-Casali L, Balli F, Magazzu G, Staiano A, Astolfi R, et al. Cimetidine treatment of reflux esophagitis in children: an Italian multicentric study. J Pediatr Gastroenterol Nutr 1989; 8:150-156. (Pubitemid 19050685)
18. Simeone D, Caria MC, Miele E, Staiano A. Treatment of childhood peptic esophagitis: a double-blind placebo-controlled trial of nizatidine. J Pediatr Gastroenterol Nutr 1997; 25:51-55. (Pubitemid 27284285)
19. Abdullah B, Gupta SK, Fitzgerald JF, Chong SKF, Croffie JM. Long-term management of moderate/severe peptic esophagitis in children/adolescents: H2-blocker versus proton pump inhibitor (PPI) [abstract]. Gastroenterol 1998; 114 (Suppl 1):A51.
20. Bourke A, Dattani H, Robinson M. Feasibility study and methodology to create a quality-evaluated database of primary care data. Inform Prim Care 2004; 12:171-177. (Pubitemid 39534583)
21. Ruigómez A, García Rodríguez LA, Wallander MA, Johansson S, Dent J. Comparison of gastroesophageal reflux disease and heartburn diagnoses in UK primary care. Curr Med Res Opin 2006; 22:1661-1668. (Pubitemid 44449221)
22. Jian R, Hassani Z, El Kebir S, Barthelemy P. Management of gastroesophageal reflux disease in primary care: results from an observational study of 2,474 patients. Gastroenterol Clin Biol 2007; 31:72-77. (Pubitemid 46212353)
23. Hassall E. Step-up and step-down approaches to treatment of gastroesophageal reflux disease in children. Curr Gastroenterol Rep 2008; 10:324-331.
24. Jones R, Liker HR, Ducrotté P. Relationship between symptoms, subjective well being and medication use in gastro-oesophageal reflux disease. Int J Clin Pract 2007; 61:1301-1307. (Pubitemid 47052376)
25. Rudolph CD, Mazur LJ, Liptak GS, Baker RD, Boyle JT, Colletti RB, et al. Guidelines for evaluation and treatment of gastroesophageal reflux in infants and children: recommendations of the North America Society for Pediatric Gastroenterology and Nutrition. J Pediatr Gastroenterol Nutr 2001; 32 (Suppl 2):S1-S31. (Pubitemid 32606853)
26. Sherman PM, Hassall E, Fagundes-Neto U, Gold BD, Kato S, Koletzko S, et al. A global, evidence-based consensus on the definition of gastroesophageal reflux disease in the pediatric population. Am J Gastroenterol 2009; 104:1278-1295.
27. Vakil N, Veldhuyzen van Zanten S, Kahrilas P, Dent J, Jones R. The Montreal definition and classification of gastro-esophageal reflux disease (GERD): a global evidence-based consensus. Am J Gastroenterol 2006; 101:1900-1920.